Clinical Trial Update: Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pharmacokinetics, safety, and outcomes of imipenem/cilastatin/relebactam in adults and adolescents with cystic fibrosis, including bact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pneumonia

Drugs mentioned

• Imipenem/Cilastatin/Relebactam (imipenem/cilastatin/relebactam)

Snippet

Sponsor: Hartford Hospital | Conditions: Cystic Fibrosis, Pneumonia, Bacterial | Phase 4 | Status: TERMINATED